David R. Stukus, MD, FACAAI
Courses
Can We Make Anaphylaxis Less Scary for Patients?
Course Credit: 1.00
Program Summary: Epinephrine is the first line therapy to treat anaphylaxis yet remains underused for a variety of reasons, including fear of needle injection or concern for adverse effects. New delivery devices, including sublingual and intranasal epinephrine, may ...